166 related articles for article (PubMed ID: 16204352)
1. Cannabinoid receptor type 2 gene is associated with human osteoporosis.
Karsak M; Cohen-Solal M; Freudenberg J; Ostertag A; Morieux C; Kornak U; Essig J; Erxlebe E; Bab I; Kubisch C; de Vernejoul MC; Zimmer A
Hum Mol Genet; 2005 Nov; 14(22):3389-96. PubMed ID: 16204352
[TBL] [Abstract][Full Text] [Related]
2. Common polymorphisms in the cannabinoid CB2 receptor gene (CNR2) are not associated with myocardial infarction and cardiovascular risk factors.
Reinhard W; Stark K; Neureuther K; Sedlacek K; Fischer M; Baessler A; Weber S; Kaess B; Wiedmann S; Erdmann J; Lieb W; Jeron A; Riegger G; Hengstenberg C
Int J Mol Med; 2008 Aug; 22(2):165-74. PubMed ID: 18636169
[TBL] [Abstract][Full Text] [Related]
3. Tumour necrosis factor superfamily member 11 gene promoter polymorphisms modulate promoter activity and influence bone mineral density in postmenopausal women with osteoporosis.
Mencej S; Albagha OM; Prezelj J; Kocjan T; Marc J
J Mol Endocrinol; 2008 Jun; 40(6):273-9. PubMed ID: 18502820
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoids and the skeleton: from marijuana to reversal of bone loss.
Bab I; Zimmer A; Melamed E
Ann Med; 2009; 41(8):560-7. PubMed ID: 19634029
[TBL] [Abstract][Full Text] [Related]
5. Combined deficiency of the Cnr1 and Cnr2 receptors protects against age-related bone loss by osteoclast inhibition.
Sophocleous A; Marino S; Kabir D; Ralston SH; Idris AI
Aging Cell; 2017 Oct; 16(5):1051-1061. PubMed ID: 28752643
[TBL] [Abstract][Full Text] [Related]
6. Haplotypes of promoter and intron 1 polymorphisms in the COLIA1 gene are associated with increased risk of osteoporosis.
Husted LB; Harsløf T; Gonzalez-Bofill N; Schmitz A; Carstens M; Stenkjaer L; Langdahl BL
Calcif Tissue Int; 2009 Feb; 84(2):85-96. PubMed ID: 19082910
[TBL] [Abstract][Full Text] [Related]
7. Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain.
Onaivi ES; Ishiguro H; Gong JP; Patel S; Perchuk A; Meozzi PA; Myers L; Mora Z; Tagliaferro P; Gardner E; Brusco A; Akinshola BE; Liu QR; Hope B; Iwasaki S; Arinami T; Teasenfitz L; Uhl GR
Ann N Y Acad Sci; 2006 Aug; 1074():514-36. PubMed ID: 17105950
[TBL] [Abstract][Full Text] [Related]
8. No association of CNR1 gene variations with susceptibility to schizophrenia.
Seifert J; Ossege S; Emrich HM; Schneider U; Stuhrmann M
Neurosci Lett; 2007 Oct; 426(1):29-33. PubMed ID: 17881126
[TBL] [Abstract][Full Text] [Related]
9. Genetics of osteoporosis.
Ralston SH
Proc Nutr Soc; 2007 May; 66(2):158-65. PubMed ID: 17466098
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoid-mediated elevation of intracellular calcium: a structure-activity relationship.
Rao GK; Kaminski NE
J Pharmacol Exp Ther; 2006 May; 317(2):820-9. PubMed ID: 16436496
[TBL] [Abstract][Full Text] [Related]
11. A nonsynonymous polymorphism in cannabinoid CB2 receptor gene is associated with eating disorders in humans and food intake is modified in mice by its ligands.
Ishiguro H; Carpio O; Horiuchi Y; Shu A; Higuchi S; Schanz N; Benno R; Arinami T; Onaivi ES
Synapse; 2010 Jan; 64(1):92-6. PubMed ID: 19768813
[TBL] [Abstract][Full Text] [Related]
12. The implication of CNR1 gene's polymorphisms in the modulation of endocannabinoid system effects.
Dinu IR; Popa S; Bîcu M; Moţa E; Moţa M
Rom J Intern Med; 2009; 47(1):9-18. PubMed ID: 19886064
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of eNOS gene polymorphisms in relation to BMD in postmenopausal women.
Firat SC; Cetin Z; Samanci N; Aydin F; Balci N; Gungor F; Firat MZ; Luleci G; Karauzum SB
Maturitas; 2009 Aug; 63(4):352-6. PubMed ID: 19520527
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of cannabinoid receptors CB1 and CB2 correlates with improved prognosis of patients with hepatocellular carcinoma.
Xu X; Liu Y; Huang S; Liu G; Xie C; Zhou J; Fan W; Li Q; Wang Q; Zhong D; Miao X
Cancer Genet Cytogenet; 2006 Nov; 171(1):31-8. PubMed ID: 17074588
[TBL] [Abstract][Full Text] [Related]
15. Association of bone metabolism related genes polymorphisms with the effect of raloxifene hydrochloride on bone mineral density and bone turnover markers in postmenopausal women with osteoporosis.
Zhang ZL; He JW; Qin YJ; Huang QR; Liu YJ; Hu YQ; Li M
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Apr; 23(2):129-33. PubMed ID: 16604479
[TBL] [Abstract][Full Text] [Related]
16. Antinociceptive effects of the non-selective cannabinoid receptor agonist CP 55,940 are absent in CB1(-/-) and not CB2(-/-) mice in models of acute and persistent pain.
Sain NM; Liang A; Kane SA; Urban MO
Neuropharmacology; 2009 Sep; 57(3):235-41. PubMed ID: 19538975
[TBL] [Abstract][Full Text] [Related]
17. A common variation in the cannabinoid 1 receptor (CNR1) gene is associated with pre-eclampsia in the Central European population.
Bienertova-Vasku J; Bienert P; Dostalova Z; Chovanec J; Vasku A; Vasku V
Eur J Obstet Gynecol Reprod Biol; 2011 Mar; 155(1):19-22. PubMed ID: 21129839
[TBL] [Abstract][Full Text] [Related]
18. Association of TNFSF11 gene promoter polymorphisms with bone mineral density in postmenopausal women.
Mencej S; Prezelj J; Kocijancic A; Ostanek B; Marc J
Maturitas; 2006 Oct; 55(3):219-26. PubMed ID: 16730419
[TBL] [Abstract][Full Text] [Related]
19. [Osteoporosis and gene polymorphism].
Hosoi T
Clin Calcium; 2004 Feb; 14(2):293-5. PubMed ID: 15576987
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid receptors in conjunctival epithelium: identification and functional properties.
Iribarne M; Torbidoni V; Julián K; Prestifilippo JP; Sinha D; Rettori V; Berra A; Suburo AM
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4535-44. PubMed ID: 18566465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
